Safety, tolerability and pharmacokinetics of SPL 7013 gel when administered vaginally, once daily for 7 days, in healthy female volunteers.
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Astodrimer (Primary)
- Indications Herpes simplex virus type 2 infections; HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 05 Nov 2010 New trial record.